# EDGAR Filing Document

**Accession Number:** 0001389933
**File Stem:** 0001389933-25-000004
**Filing Date:** 2025-8
**Character Count:** 56622
**Document Hash:** 8c5ae27601616d9f59aba625f2a75787
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001389933-25-000004.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001389933-25-000004

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DAFNA Capital Management LLC
- **CENTRAL INDEX KEY:** 0001389933

**ORGANIZATION NAME:**
- **EIN:** 364334068

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-12327
- **FILM NUMBER:** 251278457

**BUSINESS ADDRESS:**
- **STREET 1:** 10990 WILSHIRE BOULEVARD
- **STREET 2:** SUITE 1400
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90024
- **BUSINESS PHONE:** (310) 954-3200

**MAIL ADDRESS:**
- **STREET 1:** 10990 WILSHIRE BOULEVARD
- **STREET 2:** SUITE 1400
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90024

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001389933

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** DAFNA Capital Management LLC

**Address:** 10990 WILSHIRE BOULEVARD, LOS ANGELES, CA 90024

**Telephone number:** 310-954-3200

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-12327

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 254900W3EEPXDZYS3V12

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                  | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                          | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| POLYPID LTD                     | M8001Q126 | 7/2/2024       | To approve an option grant for the Company's Chief Executive Officer, Ms. DiklaCzaczkes Akselbrad, as set forth in Proposal No. 4 of the Proxy Statement.                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         184846 |                0 | FOR         |                                   184846 | FOR                         |  |
| POLYPID LTD                     | M8001Q126 | 7/2/2024       | To approve an additional milestone-based option grant for the Company's Chief Executive Officer, Ms. Dikla Czaczkes Akselbrad, as set forth in Proposal No. 5 of the Proxy Statement.                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         184846 |                0 | FOR         |                                   184846 | FOR                         |  |
| MEDIWOUND LTD                   | M68830112 | 7/9/2024       | Approval of an increase to the annual base salary (cash) compensation of the Company's Chief Executive Officer, Mr. Ofer Gonen.                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         130922 |                0 | FOR         |                                   130922 | FOR                         |  |
| MEDIWOUND LTD                   | M68830112 | 7/9/2024       | Approval of annual equity grants valued at $750,000, comprised of 80% options to purchase ordinary shares and 20% RSUs, to the Chief Executive Officer, Mr. Ofer Gonen.                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         130922 |                0 | FOR         |                                   130922 | FOR                         |  |
| MEDIWOUND LTD                   | M68830112 | 7/9/2024       | Approval of the payment of an annual cash bonus to the Company's Chief Executive Officer, Mr. Ofer Gonen, in respect of his performance in 2023.                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         130922 |                0 | FOR         |                                   130922 | FOR                         |  |
| UROGEN PHARMA LTD               | M96088105 | 8/6/2024       | To approve the Company's 2024 non-employee director and officer compensation policy.                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         469000 |                0 | FOR         |                                   469000 | FOR                         |  |
| UROGEN PHARMA LTD               | M96088105 | 8/6/2024       | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         469000 |                0 | FOR         |                                   469000 | FOR                         |  |
| IMMUNOVANT INC                  | 45258J102 | 8/12/2024      | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          47916 |                0 | FOR         |                                    47916 | FOR                         |  |
| COMPUGEN LTD                    | M25722105 | 9/12/2024      | To approve a special cash bonus to the Company's Chief Executive Officer in connection with the license agreement with Gilead Sciences, Inc.                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         467202 |                0 | FOR         |                                   467202 | FOR                         |  |
| MASIMO CORPORATION              | 574795100 | 9/19/2024      | To provide an advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           3000 |                0 | FOR         |                                     3000 | FOR                         |  |
| KALVISTA PHARMACEUTICALS INC    | 483497103 | 10/3/2024      | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         723678 |                0 | FOR         |                                   723678 | FOR                         |  |
| ACCURAY INCORPORATED            | 004397105 | 11/21/2024     | Advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        1222358 |                0 | FOR         |                                  1222358 | FOR                         |  |
| NEVRO CORP                      | 64157F103 | 4/2/2025       | To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Nevro's named executive officers that is based on or otherwise relates to the Merger.                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          38000 |                0 | FOR         |                                    38000 | FOR                         |  |
| BIOHAVEN LTD                    | G1110E107 | 5/5/2025       | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         220235 |                0 | FOR         |                                   220235 | FOR                         |  |
| DEXCOM INC                      | 252131107 | 5/8/2025       | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          65552 |                0 | FOR         |                                    65552 | FOR                         |  |
| LARIMAR THERAPEUTICS INC        | 517125100 | 5/13/2025      | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers in 2024.                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         371434 |                0 | FOR         |                                   371434 | FOR                         |  |
| CYTOKINETICS INCORPORATED       | 23282W605 | 5/14/2025      | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         398100 |                0 | FOR         |                                   398100 | FOR                         |  |
| SYNDAX PHARMACEUTICALS INC      | 87164F105 | 5/14/2025      | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         542002 |                0 | FOR         |                                   542002 | FOR                         |  |
| INOGEN INC                      | 45780L104 | 5/14/2025      | To approve, on an advisory and non-binding basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         458065 |                0 | FOR         |                                   458065 | FOR                         |  |
| MEDIWOUND LTD                   | M68830112 | 5/15/2025      | Approval of renewal for a three-year period of an updated version of the Compensation Policy for the Company's executive officers and directors.                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          64479 |                0 | FOR         |                                    64479 | FOR                         |  |
| MEDIWOUND LTD                   | M68830112 | 5/15/2025      | Approval of the payment of an annual cash bonus to the Company's Chief Executive Officer, Mr. Ofer Gonen, in respect of his performance in 2024.                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          64479 |                0 | FOR         |                                    64479 | FOR                         |  |
| BIOTECH SE                      | 09075V102 | 5/16/2025      | Resolution on the approval of the Compensation Report.                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          10500 |                0 | FOR         |                                    10500 | FOR                         |  |
| ATRICURE INC                    | 04963C209 | 5/19/2025      | Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         592273 |                0 | FOR         |                                   592273 | FOR                         |  |
| ATRICURE INC                    | 04963C209 | 5/19/2025      | Advisory vote on the frequency of future advisory votes on compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         592273 |                0 | 1 Year      |                                   592273 | FOR                         |  |
| VIKING THERAPEUTICS INC         | 92686J106 | 5/20/2025      | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          64516 |                0 | FOR         |                                    64516 | FOR                         |  |
| MERUS N.V.                      | N5749R100 | 5/21/2025      | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         475304 |                0 | FOR         |                                   475304 | FOR                         |  |
| ALIGN TECHNOLOGY INC            | 016255101 | 5/21/2025      | Advisory Vote to Approve the Compensation of our Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          11000 |                0 | FOR         |                                    11000 | FOR                         |  |
| ALKERMES PLC                    | G01767105 | 5/21/2025      | To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          94200 |                0 | FOR         |                                    94200 | FOR                         |  |
| NEUROCRINE BIOSCIENCES INC      | 64125C109 | 5/21/2025      | Advisory vote on the compensation paid to the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          71615 |                0 | FOR         |                                    71615 | FOR                         |  |
| TANDEM DIABETES CARE INC        | 875372203 | 5/21/2025      | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         294207 |                0 | FOR         |                                   294207 | FOR                         |  |
| TANDEM DIABETES CARE INC        | 875372203 | 5/21/2025      | To approve, on a non-binding, advisory basis, the frequency of future stockholder advisory votes to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         294207 |                0 | 1 Year      |                                   294207 | FOR                         |  |
| INSULET CORPORATION             | 45784P101 | 5/22/2025      | To approve, on a non-binding, advisory basis, the compensation of certain executive officers.                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          11900 |                0 | FOR         |                                    11900 | FOR                         |  |
| TELA BIO INC                    | 872381108 | 5/28/2025      | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        1441029 |                0 | AGAINST     |                                  1441029 | AGAINST                     |  |
| TELA BIO INC                    | 872381108 | 5/28/2025      | To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1441029 |                0 | 1 Year      |                                  1441029 | FOR                         |  |
| DAY ONE BIOPHARMACEUTICALS INC  | 23954D109 | 6/2/2025       | Approval, on a non-binding advisory basis, of the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         761363 |                0 | FOR         |                                   761363 | FOR                         |  |
| ADC THERAPEUTICS SA             | H0036K147 | 6/3/2025       | Approving, on an advisory basis under Swiss law, the Company's Compensation Report for the year ended December 31, 2024: The Board of Directors proposes that the Company's Compensation report for the year ended December 31, 2024, be approved in a non-binding advisory vote.                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         224081 |                0 | FOR         |                                   224081 | FOR                         |  |
| ADC THERAPEUTICS SA             | H0036K147 | 6/3/2025       | Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee: The Board of Directors proposes that the maximum aggregate amount of fixed compensation for the members of the Executive Committee for the year ending December 31, 2026, be set at $2,600,000.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         224081 |                0 | FOR         |                                   224081 | FOR                         |  |
| ADC THERAPEUTICS SA             | H0036K147 | 6/3/2025       | Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee: The Board of Directors proposes that the maximum aggregate amount of variable compensation for the members of the Executive Committee for the year ending December 31, 2025, be set at $3,500,000.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         224081 |                0 | FOR         |                                   224081 | FOR                         |  |
| ADC THERAPEUTICS SA             | H0036K147 | 6/3/2025       | Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive Officers: The Board of Directors is proposing that the following proposal: "RESOLVED, that the Company's Shareholders approve, on an advisory basis under U.S. law, the compensation of the Company's Named Executive Officers, as disclosed in "Executive Compensation" and the related compensation tables and narrative disclosure in this proxy statement", be approved. | SECTION 14A SAY-ON-PAY VOTES |         224081 |                0 | FOR         |                                   224081 | FOR                         |  |
| DENALI THERAPEUTICS INC         | 24823R105 | 6/3/2025       | Advisory vote on executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         158500 |                0 | FOR         |                                   158500 | FOR                         |  |
| STOKE THERAPEUTICS INC          | 86150R107 | 6/3/2025       | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         479998 |                0 | FOR         |                                   479998 | FOR                         |  |
| STOKE THERAPEUTICS INC          | 86150R107 | 6/3/2025       | To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         479998 |                0 | 1 Year      |                                   479998 | FOR                         |  |
| KEROS THERAPEUTICS INC          | 492327101 | 6/4/2025       | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         130316 |                0 | FOR         |                                   130316 | FOR                         |  |
| XENON PHARMACEUTICALS INC       | 98420N105 | 6/4/2025       | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         275739 |                0 | FOR         |                                   275739 | FOR                         |  |
| APREA THERAPEUTICS INC          | 03836J201 | 6/5/2025       | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         137174 |                0 | FOR         |                                   137174 | FOR                         |  |
| APREA THERAPEUTICS INC          | 03836J201 | 6/5/2025       | To approve, by non-binding advisory vote, the frequency of future votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         137174 |                0 | 1 Year      |                                   137174 | FOR                         |  |
| KURA ONCOLOGY INC               | 50127T109 | 6/5/2025       | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         463368 |                0 | FOR         |                                   463368 | FOR                         |  |
| SUTRO BIOPHARMA INC             | 869367102 | 6/6/2025       | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         437079 |                0 | AGAINST     |                                   437079 | AGAINST                     |  |
| ARCUS BIOSCIENCES INC           | 03969F109 | 6/10/2025      | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         627626 |                0 | FOR         |                                   627626 | FOR                         |  |
| PALVELLA THERAPEUTICS INC       | 697947109 | 6/10/2025      | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          43348 |                0 | FOR         |                                    43348 | FOR                         |  |
| ADICET BIO INC                  | 007002108 | 6/11/2025      | To ratify, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         600000 |                0 | FOR         |                                   600000 | FOR                         |  |
| ALECTOR INC                     | 014442107 | 6/11/2025      | Advisory vote on executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         912928 |                0 | FOR         |                                   912928 | FOR                         |  |
| AQUESTIVE THERAPEUTICS INC      | 03843E104 | 6/11/2025      | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         142000 |                0 | FOR         |                                   142000 | FOR                         |  |
| ASTRIA THERAPEUTICS INC         | 04635X102 | 6/11/2025      | The approval, by non-binding advisory vote, of our executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         324775 |                0 | FOR         |                                   324775 | FOR                         |  |
| KORRO BIO INC                   | 500946108 | 6/11/2025      | Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          47086 |                0 | FOR         |                                    47086 | FOR                         |  |
| KORRO BIO INC                   | 500946108 | 6/11/2025      | Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers.                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          47086 |                0 | 1 Year      |                                    47086 | FOR                         |  |
| SAGE THERAPEUTICS INC           | 78667J108 | 6/11/2025      | To hold a non-binding advisory vote to approve the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         108200 |                0 | FOR         |                                   108200 | FOR                         |  |
| COMPASS PATHWAYS PLC            | 20451W101 | 6/12/2025      | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2024.                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         711046 |                0 | FOR         |                                   711046 | FOR                         |  |
| BIOCRYST PHARMACEUTICALS INC    | 09058V103 | 6/12/2025      | To hold a non-binding, advisory vote regarding executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         558255 |                0 | FOR         |                                   558255 | FOR                         |  |
| NEUROGENE INC                   | 64135M105 | 6/12/2025      | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          51500 |                0 | FOR         |                                    51500 | FOR                         |  |
| SPERO THERAPEUTICS INC          | 84833T103 | 6/12/2025      | To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         125000 |                0 | FOR         |                                   125000 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC       | 28036F105 | 6/13/2025      | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         248140 |                0 | FOR         |                                   248140 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC       | 28036F105 | 6/13/2025      | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         248140 |                0 | 1 Year      |                                   248140 | FOR                         |  |
| BICYCLE THERAPEUTICS PLC        | 088786108 | 6/17/2025      | To approve, on advisory basis, the compensation of our named executive officers,as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          80799 |                0 | FOR         |                                    80799 | FOR                         |  |
| ALLOGENE THERAPEUTICS INC       | 019770106 | 6/18/2025      | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1380118 |                0 | FOR         |                                  1380118 | FOR                         |  |
| AXOGEN INC                      | 05463X106 | 6/18/2025      | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         680782 |                0 | FOR         |                                   680782 | FOR                         |  |
| AXOGEN INC                      | 05463X106 | 6/18/2025      | To recommend by a non-binding advisory vote the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         680782 |                0 | 1 Year      |                                   680782 | FOR                         |  |
| BLUEPRINT MEDICINES CORPORATION | 09627Y109 | 6/18/2025      | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         172763 |                0 | For         |                                   172763 | FOR                         |  |
| STRUCTURE THERAPEUTICS INC      | 86366E106 | 6/23/2025      | To approve, on an advisory basis, the compensation of the company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          59000 |                0 | For         |                                    59000 | FOR                         |  |
| STRUCTURE THERAPEUTICS INC      | 86366E106 | 6/23/2025      | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the company's named executive officers.                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          59000 |                0 | 1 Year      |                                    59000 | FOR                         |  |
| IDEAYA BIOSCIENCES INC          | 45166A102 | 6/24/2025      | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         651830 |                0 | For         |                                   651830 | FOR                         |  |
| POLYPID LTD                     | M8001Q126 | 6/25/2025      | To approve an option grant for the Company's Chief Executive Officer, Ms. Dikla Czaczkes Akselbrad, as set forth in Proposal No. 4 of the Proxy Statement.                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         291273 |                0 | For         |                                   291273 | FOR                         |  |
| POLYPID LTD                     | M8001Q126 | 6/25/2025      | To approve an additional milestone-based option grant for the Company's Chief Executive Officer, Ms. Dikla Czaczkes Akselbrad, as set forth in Proposal No. 5 of the Proxy Statement.                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         291273 |                0 | For         |                                   291273 | FOR                         |  |
| POLYPID LTD                     | M8001Q126 | 6/25/2025      | To approve the Proposed Compensation Policy, as set forth in Proposal No. 6 of the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         291273 |                0 | For         |                                   291273 | FOR                         |  |
| GOSSAMER BIO INC                | 38341P102 | 6/25/2025      | Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         907854 |                0 | For         |                                   907854 | FOR                         |  |
| LINEAGE CELL THERAPEUTICS INC   | 53566P109 | 6/26/2025      | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        2511374 |                0 | For         |                                  2511374 | FOR                         |  |
| CARDIFF ONCOLOGY INC            | 14147L108 | 6/26/2025      | Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         150000 |                0 | For         |                                   150000 | FOR                         |  |
| REVOLUTION MEDICINES INC        | 76155X100 | 6/26/2025      | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         678176 |                0 | For         |                                   678176 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** DAFNA Capital Management LLC

**By (Signature):** Nathan Fischel

**By (Printed Signature):** Nathan Fischel

**By (Title):** CEO

**Date:** 08/29/2025